Enanta Pharmaceuticals Inc (ENTA) — DEF 14A Filings
All DEF 14A filings from Enanta Pharmaceuticals Inc. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Enanta Pharma DEF 14A: Executive Compensation Details
— Jan 27, 2025 Risk: low
Enanta Pharmaceuticals Inc. filed its DEF 14A on January 27, 2025, for the fiscal year ending September 30, 2024. The filing details executive compensation, inc -
Enanta Pharmaceuticals Files DEF 14A with Executive Compensation Details
— Jan 26, 2024 Risk: low
ENANTA PHARMACEUTICALS INC (ENTA) filed a Proxy Statement (DEF 14A) with the SEC on January 26, 2024. Enanta Pharmaceuticals Inc. filed a DEF 14A form on Januar
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX